MARKET

CLYM

CLYM

Climb Bio
NASDAQ
10.99
-0.13
-1.17%
Opening 12:55 05/12 EDT
OPEN
11.22
PREV CLOSE
11.12
HIGH
11.33
LOW
10.80
VOLUME
131.75K
TURNOVER
--
52 WEEK HIGH
12.48
52 WEEK LOW
1.130
MARKET CAP
629.29M
P/E (TTM)
-14.1660
1D
5D
1M
3M
1Y
5Y
1D
Climb Bio to present at H.C. Wainwright BioConnect investor conference
PUBT · 5h ago
Climb Bio Price Target Raised to $20.00/Share From $15.00 by HC Wainwright & Co.
Dow Jones · 6h ago
Climb Bio Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 6h ago
Climb Bio price target raised to $20 from $15 at H.C. Wainwright
TipRanks · 6h ago
HC Wainwright & Co. Maintains Buy on Climb Bio, Raises Price Target to $20
Benzinga · 6h ago
CLIMB BIO, INC. <CLYM.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $20 FROM $15
Reuters · 6h ago
Climb Bio (CLYM) Gets a Buy from Truist Financial
TipRanks · 1d ago
Weekly Report: what happened at CLYM last week (0504-0508)?
Weekly Report · 1d ago
More
About CLYM
Climb Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics for patients with immune-mediated diseases. The Company’s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in a Phase Ib/IIa clinical trial. The Company is also developing CLYM116, an anti-APRIL antibody, in investigational new drug applications (IND)-enabling studies for IgA nephropathy (IgAN).

Webull offers Climb Bio Inc stock information, including NASDAQ: CLYM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLYM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLYM stock methods without spending real money on the virtual paper trading platform.